Cargando…

Fibrinogen concentrate for bleeding in patients with congenital fibrinogen deficiency: Observational study of efficacy and safety for prophylaxis and treatment

BACKGROUND: Congenital fibrinogen deficiency (CFD) is a rare bleeding disorder characterized by reduced levels (afibrinogenemia, hypofibrinogenemia) or dysfunctional fibrinogen (dysfibrinogenemia), for which fibrinogen supplementation is the mainstay treatment. OBJECTIVES: To assess the efficacy and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lasky, Joseph, Teitel, Jerome, Wang, Michael, Dalton, Danielle, Schmidt, Dirk Steffen, Brainsky, Andres
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Original Articles ‐ Hemostasis
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7695557/ https://www.ncbi.nlm.nih.gov/pubmed/33313470 http://dx.doi.org/10.1002/rth2.12433

Ejemplares similares

Efficacy and safety of fibrinogen concentrate for perioperative prophylaxis of bleeding in adult, adolescent, and pediatric patients with congenital fibrinogen deficiency: FORMA‐02 and FORMA‐04 clinical trials
por: Khayat, Claudia Djambas, et al.
Publicado: (2022)

Fibrinogen concentrate for treatment of bleeding and surgical prophylaxis in congenital fibrinogen deficiency patients
por: Lissitchkov, Toshko, et al.
Publicado: (2020)

Efficacy and safety of fibrinogen concentrate for on‐demand treatment of bleeding and surgical prophylaxis in paediatric patients with congenital fibrinogen deficiency
por: Djambas Khayat, Claudia, et al.
Publicado: (2020)

CD44–fibrinogen binding promotes bleeding in acute promyelocytic leukemia by in situ fibrin(ogen) deposition
por: Wang, Chunxu, et al.
Publicado: (2022)

Differential sialic acid content in adult and neonatal fibrinogen mediates differences in clot polymerization dynamics
por: Nellenbach, Kimberly, et al.
Publicado: (2021)

Extended half‐life factor VIII concentrates in adults with hemophilia A: Comparative pharmacokinetics of two products
por: Teitel, Jerome, et al.
Publicado: (2021)

Recovery of fibrinogen after administration of fibrinogen concentrate to patients with severe bleeding after cardiopulmonary bypass surgery
por: Solomon, C., et al.
Publicado: (2010)

Bleeding management with fibrinogen concentrate targeting a high-normal plasma fibrinogen level: a pilot study
por: Rahe-Meyer, N., et al.
Publicado: (2009)

Theoretical Modeling of Coagulation Management With Therapeutic Plasma or Prothrombin Complex Concentrate
por: Schöchl, Herbert, et al.
Publicado: (2017)

Two-Pronged Treatment of Hemoperitoneum and Abnormal Uterine Bleeding in an Adolescent Girl With Congenital Fibrinogen Deficiency
por: Wang, Yiran, et al.
Publicado: (2020)

Treatment of congenital fibrinogen deficiency: overview and recent findings
por: Tziomalos, Konstantinos, et al.
Publicado: (2009)

Hemophilia prophylaxis adherence and bleeding using a tailored, frequency‐escalated approach: The Canadian Hemophilia Primary Prophylaxis Study
por: Dover, Saunya, et al.
Publicado: (2020)

Analysis of fibrinogen concentrate pharmacokinetics and dosing for bleeds and surgery in adults, adolescents, and children with congenital afibrinogenaemia and hypofibrinogenaemia
por: Djambas Khayat, Claudia, et al.
Publicado: (2022)

Theoretical modelling of fibrinogen supplementation with therapeutic plasma, cryoprecipitate, or fibrinogen concentrate
por: Collins, P. W., et al.
Publicado: (2014)

Fibrinogen Deficiency with Thrombotic Manifestations
por: Tamayo-Velasco, Álvaro, et al.
Publicado: (2022)

Fibrinogen, Fibrinogen-like 1 and Fibrinogen-like 2 Proteins, and Their Effects
por: Sulimai, Nurul H., et al.
Publicado: (2022)

Thrombocytopenia in cirrhosis: Impact of fibrinogen on bleeding risk
por: Thakrar, Sonali V, et al.
Publicado: (2017)

COVID-19 coagulopathy, thrombosis, and bleeding
por: Chan, Noel C., et al.
Publicado: (2020)

The bleeding phenotype in people with nonsevere hemophilia
por: Kloosterman, Fabienne R., et al.
Publicado: (2022)

Structural and Functional Characterization of Four Novel Fibrinogen Mutations in FGB Causing Congenital Fibrinogen Disorder
por: Ceznerová, Eliška, et al.
Publicado: (2022)

Desmopressin responsiveness by age in type 1 von Willebrand disease
por: Goldberg, Nicola, et al.
Publicado: (2020)

Over 50 Years of Fibrinogen Concentrate
por: Costa-Filho, Rubens, et al.
Publicado: (2015)

Treatment of Obstetric Hemorrhage with Fibrinogen Concentrate
por: Sahin, Ayca Sultan, et al.
Publicado: (2019)

Proposed fibrinogen standard material with purified fibrinogen for plasma fibrinogen measurement on coagulation analyser
por: Okuda, Masahiro, et al.
Publicado: (2003)

Fibrinogen Gamma Chain Mutations Provoke Fibrinogen and Apolipoprotein B Plasma Deficiency and Liver Storage
por: Callea, Francesco, et al.
Publicado: (2017)

Rivaroxaban vs placebo for extended antithrombotic prophylaxis after laparoscopic surgery for colorectal cancer
por: Becattini, Cecilia, et al.
Publicado: (2022)

Pediatric Fibrinogen PART I—Pitfalls in Fibrinogen Evaluation and Use of Fibrinogen Replacement Products in Children
por: Huisman, Elise J., et al.
Publicado: (2021)

Venous thromboembolism prophylaxis in sickle cell disease: a multicenter cohort study of adolescent inpatients
por: Davila, Jennifer, et al.
Publicado: (2022)

COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection
por: Al-Samkari, Hanny, et al.
Publicado: (2020)

An engineered activated factor V for the prevention and treatment of acute traumatic coagulopathy and bleeding in mice
por: Joseph, Bilgimol Chumappumkal, et al.
Publicado: (2022)

Predicting major bleeding during extended anticoagulation for unprovoked or weakly provoked venous thromboembolism
por: Wells, Philip S., et al.
Publicado: (2022)

Plasma Fibrinogen Concentration in Occlusive Arterial Disease
por: Ingram, G. I. C.
Publicado: (1952)

Quantile-specific heritability of plasma fibrinogen concentrations
por: Williams, Paul T.
Publicado: (2022)

Thromboembolic events, bleeding, and mortality in patients with cerebral venous thrombosis: a nationwide cohort study
por: Skajaa, Nils, et al.
Publicado: (2022)

Prevalence and risk factors for bleeding in hereditary hemorrhagic telangiectasia: a National Inpatient Sample study
por: Zarka, Jabra, et al.
Publicado: (2023)

Effects of pathogen reduction technology and storage duration on the ability of cryoprecipitate to rescue induced coagulopathies in vitro
por: Thomas, Kimberly A., et al.
Publicado: (2021)

Soluble protein C receptor: why?
por: Geiger, Margarethe
Publicado: (2008)

Screening platelet function in blood donors
por: Pedini, Pascal, et al.
Publicado: (2022)

Whole-exome analysis of adolescents with low VWF and heavy menstrual bleeding identifies novel genetic associations
por: Sadler, Brooke, et al.
Publicado: (2022)

Fibrinogen and Atherosclerosis
por: Cerit, Levent
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_f0ohd090lil418pbsqmnl9ev92